Get the Stockscreener App
0.468
3.17%
-0.0153
After Hours:
.47
0.002
+0.43%
Klotho Neurosciences Inc stock is traded at $0.468, with a volume of 900.48K.
It is down -3.17% in the last 24 hours and down -21.24% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.4833
Open:
$0.47
24h Volume:
900.48K
Relative Volume:
0.47
Market Cap:
$28.72M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-1.0277
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
-11.71%
1M Performance:
-21.24%
6M Performance:
+181.93%
1Y Performance:
+20.00%
1-Day Range:
$0.4558
$0.49
1-Week Range:
$0.4431
$0.5454
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.468 | 29.66M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Klotho Neurosciences (NASDAQ: KLTO) wins 'Cell Therapy Innovation of the Year' award - Stock Titan
Is Klotho Neurosciences Inc. stock a safe investment in uncertain marketsTrade Performance Summary & Smart Swing Trading Techniques - newser.com
Klotho Neurosciences Inc. Equity Warrant’s volatility index tracking explainedInsider Selling & Fast Gain Swing Alerts - newser.com
What indicators show strength in Klotho Neurosciences Inc. Equity WarrantLayoff News & Verified Short-Term Plans - newser.com
Is Klotho Neurosciences Inc. Equity Warrant stock attractive after correctionDollar Strength & Fast Moving Stock Trade Plans - newser.com
Why Klotho Neurosciences Inc. stock remains on watchlistsJuly 2025 Technicals & Daily Stock Trend Reports - fcp.pa.gov.br
Why Klotho Neurosciences Inc. stock remains a top recommendationMarket Movers & AI Enhanced Market Trend Forecasts - fcp.pa.gov.br
Price momentum metrics for Klotho Neurosciences Inc. explainedExit Point & AI Driven Price Predictions - newser.com
Is Klotho Neurosciences Inc. stock overvalued by current metrics2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
Will Klotho Neurosciences Inc. Equity Warrant continue its uptrendJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Is Klotho Neurosciences Inc. stock ready for a breakoutWeekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com
Can Klotho Neurosciences Inc. stock attract ESG capital inflowsJuly 2025 Catalysts & Weekly Breakout Watchlists - fcp.pa.gov.br
Can you recover from losses in Klotho Neurosciences Inc.2025 Market Trends & Daily Growth Stock Investment Tips - newser.com
Is Klotho Neurosciences Inc. stock supported by strong fundamentalsQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
What technical models suggest about Klotho Neurosciences Inc. Equity Warrant’s comebackQuarterly Portfolio Report & Real-Time Buy Zone Alerts - newser.com
Will a bounce in Klotho Neurosciences Inc. Equity Warrant offer an exitQuarterly Portfolio Report & High Accuracy Buy Signal Tips - newser.com
Building trade automation scripts for Klotho Neurosciences Inc. Equity WarrantWeekly Risk Report & Consistent Profit Alerts - newser.com
Is Klotho Neurosciences Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
What to expect from Klotho Neurosciences Inc. in the next 30 daysWeekly Trend Report & Breakout Confirmation Alerts - newser.com
Will Klotho Neurosciences Inc. stock split attract more investors2025 Support & Resistance & AI Enhanced Execution Alerts - fcp.pa.gov.br
Published on: 2025-11-05 20:42:33 - fcp.pa.gov.br
Is Klotho Neurosciences Inc. stock in correction or buying zoneJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - newser.com
How to interpret RSI for Klotho Neurosciences Inc. stockQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Will Klotho Neurosciences Inc. Equity Warrant stock attract ESG investorsJuly 2025 Analyst Calls & Consistent Profit Trade Alerts - fcp.pa.gov.br
Is now a turning point for Klotho Neurosciences Inc.July 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Will Klotho Neurosciences Inc. stock benefit from commodity pricesWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
How institutional buying supports Klotho Neurosciences Inc. Equity Warrant stockJuly 2025 Sector Moves & Stock Portfolio Risk Management - newser.com
What analysts say about Klotho Neurosciences Inc Equity Warrant stockHigh Yield Income Stocks & 5 Stocks Every Investor Should Own - earlytimes.in
Will Klotho Neurosciences Inc. Equity Warrant stock sustain high P E ratiosPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):